Navigation Links
FDA Advisory Committee Unanimously Recommends Approval of HRA Pharma's Ulipristal Acetate for Emergency Contraception
Date:6/17/2010

PARIS, June 17 /PRNewswire/ -- www.hra-pharma.com -HRA Pharma announced today that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive.

The committee's vote followed a review of data from the ulipristal acetate preclinical and clinical development program. Involving more than 4000 women from the U.S. and Europe, it is the largest development program ever conducted in the emergency contraceptive field.

"HRA Pharma is pleased with the outcome of the Advisory Committee's votes on the safety and effectiveness of ulipristal acetate," said Erin Gainer, CEO of HRA Pharma.  "We look forward to working with the FDA to obtain approval for this new drug and offering a next-generation emergency contraceptive to women in the U.S."

The FDA is currently reviewing HRA Pharma's New Drug Application (NDA) for ulipristal acetate.  While today's vote may be considered, the Agency is not bound by the recommendations of its advisory committees.

Ulipristal acetate was approved in May 2009 by the European Commission for marketing as an emergency contraceptive within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure. The product was launched in October 2009 and is marketed today in 22 European countries
'/>"/>

SOURCE HRA Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AstraZeneca Comments on FDA Joint Advisory Committee Meeting on Post-Marketing Safety Studies for the Use of LABAs in Asthma
2. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
3. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
4. InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
5. American Heart Association/American College of Cardiology Joint Science Advisory: AHA/ACC Issue Advisory on Diabetes Drugs and Heart Risk
6. Caliper Life Sciences Forms Scientific Advisory Board for Next Generation Sequencing
7. Government Relations CEO Joins MedeFile Advisory Board
8. Frank Phillips, Paul Anderson and Federico Girardi Join SI-BONEs Medical Advisory Board
9. Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D.
10. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
11. InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ZIONA, Israel , June 29, ... BVXV, TASE: BVXV) today announced positive preliminary results from ... candidate for a universal influenza vaccine. In this trial, ... of 50 to 65, followed by an administration of ... later. M-001 was found to be safe and well ...
(Date:6/29/2015)... Calif. , June 29, 2015  Isis Pharmaceuticals, ... has been added to the Russell 1000 Index, effective ... performance of the large-cap segment of the U.S. equity ... Index and includes approximately 1000 of the largest securities ... current index membership. "We are pleased to ...
(Date:6/29/2015)... Calif. , June 29, 2015  Arbor ... medical workstation lineup. The high-powered, multi-functional M2150 ... generation Intel® Haswell Core i5-4402E 1.6 ... provide significant data processing and computing performance. Integrated ... making the unit well suited for graphics-intense applications ...
Breaking Medicine Technology:BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 2ISIS Pharmaceuticals Promoted to the Large-Cap Russell 1000 Index 3Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... , CHEYENNE, Wyo., Aug. 24 The ... of its Pay-for-Participation (P4P) program, a component of its innovative ... collaboration between the practitioner community and the Wyoming EqualityCare (EC) ... Wyoming Medicaid members. , , (Logo: ...
... Curemark Founder and CEO Dr. Joan Fallon delivered the ... Conference at Harvard Medical School on July 14th. , ... conclave is particularly significant, since epigenetics is the study of ... in the DNA sequence. Presenters at the session showcased many ...
Cached Medicine Technology:Wyoming Department of Health's Pay-for-Participation Program Reports Positive Clinical Outcomes 2Wyoming Department of Health's Pay-for-Participation Program Reports Positive Clinical Outcomes 3Curemark CEO Presents at Epigenomics Conference 2
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... have developed a new approach to build nearly complete genomes by combining high-throughput ... of genomic variation, critically important for their association with human disease, but previously ...
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... to healthcare providers for patients with certain neuropsychiatric and chronic pain conditions, has ... and CEO. , The appointments include: Peter Donato, Senior Vice President, Chief Financial ...
(Date:6/29/2015)... ... ... OR Manager announced Monday the launch of an enhanced http://www.ormanager.com . The ... and weekly eLetter. The website contains the same informational articles, products, and resources that ... , In addition to a refreshed look, http://www.ormanager.com now provides users with ...
(Date:6/29/2015)... York, NY (PRWEB) , ... June 29, 2015 ... ... dietary supplement with Citicoline (Cognizin®) from Kyowa Hakko Bio to French consumers. , ... the macular cells from oxidative stress caused by free radicals. In addition to ...
(Date:6/29/2015)... ... June 29, 2015 , ... FACE is proud to be one of ... reduction of the double chin and redefining of the jawline. Excess fat under ... older and heavier causing the person distress and poor self-image. , Kybella was produced ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 2Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 3Health News:Mount Sinai Scientists Develop New Approach for More Accurate and Comprehensive Whole Genome Assembly, Variant Discovery and Interpretation 4Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3Health News:OR Manager Launches New Website 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 3Health News:FACE Detroit Skin and Wellness Clinic Introduces Newly FDA Approved Kybella for the elimination of the Double Chin. 2
... ... Best Nursing Homes” List , ... Tucson, Ariz. (Vocus) February 2, 2010 -- A Tucson retirement community’s health ... by U.S. News and World Report. The designation will appear in the national magazine’s ...
... , INDIANAPOLIS , Feb. 2 ... senior management is scheduled to present at the UBS 20th Annual ... 8:00 a.m. Eastern Standard Time .   , All interested ... by visiting www.wellpoint.com and selecting the "Investor ...
... the University of Pennsylvania School of Medicine have found ... a toxic form of the same protein. The protein, ... that are the hallmarks of Parkinson,s disease, Alzheimer,s disease, ... molecular link between the presence of inclusions and neuronal ...
... study found , TUESDAY, Feb. 2 (HealthDay News) -- ... who are at risk for kidney failure and associated problems, ... in the Feb. 3 issue of the Journal of ... for protein levels in urine (proteinuria) be incorporated into upcoming ...
... , SOMERSET, N.J. , Feb. 2 ... logistical staffing provider serving the Federal Government, today announced that it ... the Company has regained compliance with the $1.00 per ... Nasdaq Capital Market, pursuant to the Nasdaq Marketplace Rules. In the ...
... link between MMR vaccine, developmental disorder , TUESDAY, ... journal The Lancet on Tuesday formally retracted ... mumps and rubella vaccine to autism and gastrointestinal problems. ... 1998, set off a worldwide furor, with many researchers ...
Cached Medicine News:Health News:U.S. News & World Report Ranks Sonora at Splendido Among Top in Nation 2Health News:WellPoint Announces Appearance at Upcoming Conference 2Health News:WellPoint Announces Appearance at Upcoming Conference 3Health News:3 brain diseases linked by toxic form of same neural protein 2Health News:Protein Levels in Urine Help Predict Kidney Function 2Health News:Protein Levels in Urine Help Predict Kidney Function 3Health News:TeamStaff Regains Compliance with Nasdaq $1.00 Minimum Bid Rule 2Health News:TeamStaff Regains Compliance with Nasdaq $1.00 Minimum Bid Rule 3Health News:Controversial Autism Study Retracted by Medical Journal 2Health News:Controversial Autism Study Retracted by Medical Journal 3Health News:Controversial Autism Study Retracted by Medical Journal 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: